# Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study

> **NCT06747039** · — · RECRUITING · sponsor: **I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio** · enrollment: 38 (estimated)

## Conditions studied

- Fibromyalgia (FM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06747039
- **Lead sponsor:** I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-05
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747039, "Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT06747039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*